SCHEMBL3937875

SCHEMBL3937875

CC(C)CCOc1ccc(CC(=O)O)cc1CN1CCNCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.48
ALDH1A1 P00352 2/20 0.43
PKM P14618 2/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
S1PR1 P21453 1/20 0.42
S1PR5 Q9H228 1/20 0.42
PTGDR2 Q9Y5Y4 9/20 0.41
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
CYP1A2 P05177 1/20 0.39
CHRM2 P08172 1/20 0.39
SLC6A4 P31645 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
CXCR3 P49682 1/20 0.39
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3929761 0.90 NPSR1 (0.47) NPSR1ALDH1A1PKMMAPTTSHR
Piperazine SCHEMBL27767250 0.89 NPSR1 (0.46) NPSR1ALDH1A1PKMMAPTTSHR
SCHEMBL3933704 0.86 NPSR1 (0.47) NPSR1ALDH1A1PKMMAPTTSHR
SCHEMBL3928450 0.81 FAAH (0.56)
SCHEMBL3926126 0.80 PTGDR2 (0.49) ALDH1A1PKMMAPTHTTTHRB
SCHEMBL3929765 0.78 NPSR1 (0.46) NPSR1ALDH1A1PKMMAPTTSHR
SCHEMBL14367071 0.75 ALDH1A1 (0.54) ALDH1A1PKMMAPTTSHRHTT
SCHEMBL4280876 0.75 THRA (0.47) NPSR1ALDH1A1HTTTHRATHRB
SCHEMBL3933705 0.74 THRA (0.43) THRATHRBPTGDR2GAACXCR3
SCHEMBL3937822 0.73 FAAH (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044044-A2 SUBSTITUTED PHENYL ACETIC ACIDS AS DP-2 ANTAGONISTS ICOS CORPORATION (US) 2009-04-08 EP disclosed
WO-2007143745-A2 SUBSTITUTED PHENYL ACETIC ACIDS AS DP-2 ANTAGONISTS ICOS CORPORATION (US) 2007-12-13 WO disclosed